Skip to main content
GutCited

커큐민 그림

8 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 1 Schematic illustration of turmeric-derived nanoparticles (TDNPs 2) isolation and targeted ulcerative colitis (UC) therapy via oral administration. A TDNPs 2 were isolated and purified from edible turmeric by ultracentrifugation and sucrose gradient
Figure 1 Diagram

Turmeric-derived nanoparticles (TDNPs 2) are isolated through sucrose gradient ultracentrifugation and administered orally to target inflamed colonic tissue in a murine colitis model. The schematic outlines the isolation workflow from edible turmeric to purified nanovesicles.

Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for …

Figure 1. Immunomodulation by natural product compounds involves an altered balance between subsets of diverse immune cell types. The corresponding pathogenic (pro-inflammatory) (Right panel) versus protective (anti-inflammatory/immunomodulatory) (Left pane
Figure 6 Diagram

Natural product compounds shift the balance between pathogenic pro-inflammatory immune cells (right panel) and protective anti-inflammatory/immunomodulatory cell subsets (left panel). This diagram illustrates how diverse natural products can rebalance immune cell populations in autoimmune disease.

The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation.

Figure 8
Figure 8 Diagram

Clinical translation of natural anti-inflammatory products requires understanding of bioavailability and dose-response relationships. This figure discusses the therapeutic potential and limitations of natural product-based interventions for autoimmune conditions.

The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation.

Figure 1. Schematic of TLR4/NF-κB/AP-1 signaling.
Figure 5 Diagram

TLR4/NF-kB/AP-1 signaling is a key inflammatory pathway in intestinal disease. This schematic illustrates the cascade from TLR4 receptor activation through NF-kB and AP-1 transcription factors to pro-inflammatory gene expression, and indicates where curcumin may intervene.

Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.

Figure 1. Inflammatory bowel diseases (IBD), activation of the nuclear factor-kB (NF-kB), and the possible roles of phytochemicals against this pathway activation during these diseases. ↑, increase; TLRs, Toll-like receptors; IKKα, IkappaB kinase alfa; IKK
Figure 6 Diagram

Inflammatory bowel diseases are associated with activation of the NF-kB signaling pathway. This diagram illustrates how various phytochemicals may counteract NF-kB pathway activation through inhibition of Toll-like receptors, IKK complex, and downstream transcriptional targets in IBD.

Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of …

Figure 218
Figure 218 Diagram

Supplementary figure from a comprehensive review of phytochemical effects on NF-kB regulation in inflammatory bowel disease. The review examines multiple plant-derived compounds with potential to attenuate chronic intestinal inflammation through modulation of key signaling pathways.

Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of …

Figure 1. The curcumin activity in mucosal.
Figure 1 Diagram

Curcumin's activity in the intestinal mucosa is illustrated, highlighting its anti-inflammatory mechanisms in the gastrointestinal tract. The diagram depicts how curcumin may modulate immune signaling pathways relevant to inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.

Figure 2
Figure 2 Diagram

Molecular pathways and cellular targets of curcumin in inflammatory bowel disease are presented. The anti-oxidant and anti-inflammatory properties of curcumin are linked to its potential therapeutic applications in managing chronic gastrointestinal inflammation.

Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.